Search research articles
Contact Us
Filters
Showing results (111-120 of 283) with videos related to
Page
of 29
Sort By:
JACC. Cardiooncology
|
March 6, 2023
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: <i>JACC: CardioOncology</i> State-of-the-Art Review
Georgios Georgiopoulos, Nikolaos Makris, Ageliki Laina, et al.
Proteomics. Clinical Applications
|
August 29, 2025
Serum Proteomics of Ribociclib-Mediated Cardiovascular Toxicity: An Exploratory Case-Control Study
Oraianthi Fiste, Martina Samiotaki, Efstathios Manios, et al.
British Journal of Haematology
|
August 26, 2004
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)
Marianna Politou, Evangelos Terpos, Athanasios Anagnostopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers
Giannis Mountzios, David Planchard, Benjamin Besse, et al.
Leukemia
|
July 2, 2025
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Panagiotis Malandrakis, et al.
Haematologica
|
May 10, 2007
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, et al.
Journal of Clinical Medicine
|
November 25, 2023
Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection
Efstathia Liatsou, Ioanna Tatouli, Andreas Mpozikas, et al.
Hellenic Journal of Nuclear Medicine
|
December 15, 2015
Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy
Vasileios Papantoniou, Pipitsa Valsamaki, Stathis Kastritis, et al.
European Journal of Clinical Investigation
|
October 22, 2025
GLP-1 receptor agonists in patients with MGUS: A real-world propensity-matched study
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, et al.
Frontiers in Oncology
|
April 11, 2022
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
Stavroula A Paschou, Michael Liontos, Evangelos Eleftherakis-Papaiakovou, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 283) with videos related to
Sort By:
Page
of 29
JACC. Cardiooncology
|
March 6, 2023
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: <i>JACC: CardioOncology</i> State-of-the-Art Review
Georgios Georgiopoulos, Nikolaos Makris, Ageliki Laina, et al.
Proteomics. Clinical Applications
|
August 29, 2025
Serum Proteomics of Ribociclib-Mediated Cardiovascular Toxicity: An Exploratory Case-Control Study
Oraianthi Fiste, Martina Samiotaki, Efstathios Manios, et al.
British Journal of Haematology
|
August 26, 2004
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)
Marianna Politou, Evangelos Terpos, Athanasios Anagnostopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers
Giannis Mountzios, David Planchard, Benjamin Besse, et al.
Leukemia
|
July 2, 2025
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Panagiotis Malandrakis, et al.
Haematologica
|
May 10, 2007
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, et al.
Journal of Clinical Medicine
|
November 25, 2023
Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection
Efstathia Liatsou, Ioanna Tatouli, Andreas Mpozikas, et al.
Hellenic Journal of Nuclear Medicine
|
December 15, 2015
Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy
Vasileios Papantoniou, Pipitsa Valsamaki, Stathis Kastritis, et al.
European Journal of Clinical Investigation
|
October 22, 2025
GLP-1 receptor agonists in patients with MGUS: A real-world propensity-matched study
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, et al.
Frontiers in Oncology
|
April 11, 2022
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
Stavroula A Paschou, Michael Liontos, Evangelos Eleftherakis-Papaiakovou, et al.
Page
of 29